The Bill & Melinda Gates Foundation has looked at a lot of different ways to get the most bang for every buck it puts into global health. Now its new global health leader, Trevor Mundel, says he hopes to do that by making more equity investments in biotech companies.
Mundel, a former Novartis executive, said this week in an interview with the Financial Times that the foundation plans to take equity stakes in as many as a dozen biotech companies, which will likely get a few million dollars each.
